You have read all your free articles, to continue reading subscribe to read the rest of this content.
Swedish Cantargia and Panorama Research Inc, a California based specialist antibody developer, have entered into a collaboration agreement to jointly accelerate Cantargia's second program directed towards autoimmune and inflammatory diseases. Cantargia's antibodies, against the molecular target IAlready a subscriber Login You have read all your free articles, to continue reading…
Roche and DexTech have signed a research agreement with the aim to share DexTech’s know-how and proprietary glycosylation technology for applications in one of Roche’s oncology projects based on monoclonal antibodies. DexTech owns two globally granted patents relating to electrostatically modifiAlready a subscriber Login You have read all your free…
Vaccibody has decided to change its financial reporting from NGAAP (Norwegian Generally Accepted Accounting Principles) and instead adopt IFRS (International Financial Reporting Standards) as its new accounting standard. Vaccibody has experienced a continued growing international interest in its Already a subscriber Login You have read all your free articles, to…
The Board of Directors of Xbrane Biopharma has successfully completed a directed issue of 3,853,799 shares corresponding to approximately SEK 146 million before costs related to the transaction. The subscription price in the Directed Share Issue has been determined to 38 SEK per share through an Already a subscriber Login…
